What is Ultherapy?
Ultherapy specializes in a non-invasive skin lifting treatment that leverages micro-focused ultrasound energy to promote collagen production. This FDA-cleared procedure is recognized as the Gold Standard for nonsurgical skin lifting, targeting areas such as the neck, brows, and under the chin. With a reported 95% patient satisfaction rate at one year post-treatment, Ultherapy offers an effective solution for individuals seeking skin tightening without surgical intervention. The company utilizes real-time imaging technology to personalize treatments, ensuring both safety and efficacy for its clientele.
How much funding has Ultherapy raised?
Ultherapy has raised a total of $38.5M across 3 funding rounds:
Series B
$22.5M
Series C
$10.5M
Series A
$5.5M
Series B (2008): $22.5M with participation from New Enterprise Associates and 3i Group
Series C (2011): $10.5M led by New Enterprise Associates and Apposite Capital
Series A (2020): $5.5M supported by 3i
Key Investors in Ultherapy
New Enterprise Associates
New Enterprise Associates is a prominent venture capital firm known for investing in companies across various stages of growth, often focusing on technology and healthcare sectors.
3i Group
3i Group is a private equity firm that invests in mid-market businesses, providing capital for growth, acquisitions, and buyouts, with a diverse portfolio across multiple industries.
Apposite Capital
Apposite Capital is an investment firm that typically focuses on healthcare and life sciences companies, providing strategic capital to support innovation and expansion within the sector.
What's next for Ultherapy?
The recent major strategic investment in Ultherapy signals a pivotal phase for the company, likely focused on expanding its market penetration, enhancing its technological capabilities, or potentially exploring new therapeutic applications within the aesthetics industry. Given its established position and the substantial capital infusion, Ultherapy is poised for further innovation and market leadership. Future developments may include broader geographic reach, advancements in treatment protocols, or strategic partnerships to solidify its 'Gold Standard' status in the competitive non-invasive cosmetic procedure landscape.
See full Ultherapy company page
